Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duodopa Extension Study in Advanced Parkinson's Disease
NCT02082249Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Mar 2014
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of levodopa in Parkinson's disease (PD), sponsored by AbbVie Inc.. Started Mar 2014; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02082249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02082249.